J2KBIO Co., Ltd. (KOSDAQ:420570)
9,430.00
-780.00 (-7.64%)
At close: Sep 3, 2026
| Market Cap | 55.20B +3.9% |
| Revenue (ttm) | 43.90B +51.0% |
| Net Income | 5.81B +401.8% |
| EPS | 994.44 +392.6% |
| Shares Out | 5.85M |
| PE Ratio | 9.49 |
| Forward PE | n/a |
| Dividend | 250.00 (2.65%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 71,111 |
| Open | 10,220.00 |
| Previous Close | 10,210.00 |
| Day's Range | 9,350.00 - 10,280.00 |
| 52-Week Range | 6,710.00 - 12,860.00 |
| Beta | 0.30 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 12, 2026 |